国产99久久精品_欧美日本韩国一区二区_激情小说综合网_欧美一级二级视频_午夜av电影_日本久久精品视频

意大利百勝Esaote
百勝是世界領先的醫療診斷系統生產廠商之一，以歐洲為基地的領先的超聲設備制造商，國際公認的專用磁共振設備的領軍者，百勝在健康信息技術方面也是主力軍之一.

25年來,百勝穩步成長。2006年凈銷售超過2.6億歐元，相當于全球范圍銷售的60%。百勝約有85%的銷售出自競爭激烈的市場，如歐洲、美國和中國。

今天，百勝集團約有1200名雇員，39%的員工在海外工作。研發部門約有260名有資質的技術人員（相當于全部雇員人數的20%以上），并參與國際性研究中心和大學合作。

1980年代初，百勝開始起步。

1980年代初， 安薩爾多生物醫療公司成立
1988年 - Ote Biomedica公司與Esacontrol公司的一個部門合并，成立百勝生物醫療公司
1991年 - 收購位于美國印地安那波里斯的Biosound公司，開始國際化進程
1992年 - 百勝荷蘭公司和法國公司成立
1994年 - 投資者和百勝管理層收購公司股份，實現私有化
1996年 - 米蘭證交所上市
1997年 - 百勝（中國有）限公司成立
1998年 - 收購荷蘭派爾集團
1998年 - 博萊科成為主要股東
2003年 - 博萊科發起兼并，認購100%的股份資本
2004年 - 在中國深圳成立合資企業深圳百勝醫療科技有限公司
2006年 - 以Banca Intesa為首的投資者和以百勝董事會主席Carlo Castellano教授為首的百勝集團管理層收購100% 百勝股份
2007年 - 收購法國康強醫療公司
2007年 - 創建百勝印度亞太診斷設備公司
2007年 - 百勝和EbitAet S.p.A.及Imaging S.p.A.合并

Esaote is one of the world’s leading producers of medical diagnostic systems. It is well established as a Europe-based leading ultrasound manufacturer, and internationally acknowledged to be the world leader in dedicated MRI. The Esaote Group is also one of the main players in the sector of Information Technology for healthcare.

In January 2006 a new Company - called Imaging S.p.A. - was created in order to purhcase 100% of Esaote S.p.A. and its subsidiaries. Imaging was created by financial investors (Intesa San Paolo, Equinox, Mps Venture, Banca Carige) and by the managers of the Esaote Group. During 2006 and 2007 Imaging S.p.A. was a shareholder of Esaote and had no operative functions.

In November 2009 Esaote is acquired by Tutti S.p.A., a consortium of investors led by Ares Life Sciences holding 40% of the share capital, and including Intesa Sanpaolo, Equinox Two SCA, MPS Venture 2, Carige and a group of Esaote management, holding a combined 60% stake.

During its life Esaote has undergone a steady growth, achieving net sales of about 310 million euro in 2009 with a strong contribution of international sales equal to about 60%. Almost 85% of Esaote’s consolidated sales are derived from highly competitive markets such as European countries, USA and China.

Today the Esaote Group has about 1350 employees, 40% of which work abroad. The R&D structures employ about 270 qualified technicians (equal to 20% of total staff) and enjoy the co-operation of international research centres and universities.

 Early 1980’s - Ansaldo Biomedicale founded
1988 - Ote Biomedica and a division of Esacontrol merge to create Esaote Biomedica
1991 - Internationalization begun with Biosound, Indianapolis, USA
1992 - Esaote Biomedica Deutschland and Esaote France created
1994 - Management Buy-out of Esaote, backed by leading investors and privatization
1996 - Listed on the Milan Stock Exchange
1997 - Esaote China set up
1998 - Pie Medical Group (Holland) acquired (today Esaote Europe)
1998 - Bracco becomes major stakeholder
2003 - Bracco launches a take-over bid and subscribes to 100% of the share capital
2004 - SEMT joint venture set up in Shenzhen (People’s Republic of China)
2006 - 100% of Esaote acquired by Imaging S.p.A. , a company set up by a group of investors, together with the management
2007 - Kontron Medical (France) acquired
2007 - Esaote Asia Pacific Diagnostic, (New Delhi,India) created
2007 - Esaote S.p.A and EbitAet S.p.A. merge with Imaging S.p.A. and Imaging S.p.A. changes its name to Esaote S.p.A.
2008 - Esaote S.p.A. purchases 79% of Anima Medica LtdA, a company based in San Paolo, Brasil. This company distributes Esaote products in Brasil with the trademark "Esaote Healthcare do Brasil".
2009 - Esaote is acquired by Tutti S.p.A. - 3rd Management Buy-Out